Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy

被引:8
|
作者
Mannucci, Pier Mannuccio [1 ]
Galbussera, Alessia Antonella [2 ]
D'Avanzo, Barbara [2 ]
Tettamanti, Mauro [2 ]
Remuzzi, Giuseppe [2 ]
Fortino, Ida [3 ]
Leoni, Olivia [3 ]
Harari, Sergio [4 ,5 ]
Nobili, Alessandro [2 ]
机构
[1] Fdn IRCCS CaGranda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] IRCCS, Dept Hlth Policy, Ist Ric Farmacol Mario Negri, Via Mario Negri 2, I-20156 Milan, Italy
[3] Direz Gen Welf, Milan, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[5] Multimed IRCSS, Div Internal Med, Milan, Italy
关键词
Alpha; Delta; Omicron variants; Population study; Administrative database;
D O I
10.1007/s11739-023-03315-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lombardy, the largest and most densely populated Italian region, was severely hit in February 2020 by the first pandemic wave of SARS-CoV-2 and associated COVID-19. Since then, additional infection waves spread in the region. The aim of this study was to compare the first with the subsequent waves using the administrative database of the Lombardy Welfare directorate. In the time frames of the four 2020-2022 waves, the absolute number of infected cases, sites of management and crude mortality rate associated with SARS-CoV-2 positivity were extracted from the database. Infected cases progressively increased in the region by approximately 5-fold in the second versus the first wave, 4-fold in the third and 20-fold during the most recent wave mainly associated with the omicron variant. The crude death decreased from 18.7% in the first to 2% in the second and third wave to reach a 0.3% nadir at the time of the fourth wave. This study confirms that in Lombardy outcomes of public health and health-care relevance such as deaths and number of hospitalizations declined dramatically across the four virus waves and reached very low values in 2022 when, at variance with the first three SARS-CoV-2 waves, the majority of infected cases had been previously vaccinated.
引用
收藏
页码:1445 / 1451
页数:7
相关论文
共 50 条
  • [21] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [22] Tracking SARS-CoV-2 in urban wastewater samples during the first wave of COVID-19 epidemic in Lombardy (Italy)
    Pellegrinelli, L.
    Schiarea, S.
    Primache, V.
    Galli, C.
    Bubba, L.
    Mancinelli, F.
    Cereda, D.
    Ammoni, E.
    Pariani, E.
    Castiglioni, S.
    Zuccato, E.
    Binda, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S100 - S101
  • [23] SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic
    Erensoy, Selda
    MIKROBIYOLOJI BULTENI, 2020, 54 (03): : 497 - 509
  • [24] Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemic
    Brufsky, Adam
    Lotze, Michael T.
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2379 - 2380
  • [25] Consequences of the COVID-19/SARS-CoV-2 pandemic for gastroenterology in Germany
    Frieling, Thomas
    GASTROENTEROLOGE, 2020, 15 (06): : 498 - 505
  • [26] Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
    Gonzalez-Vazquez, Luis Daniel
    Arenas, Miguel
    GENES, 2023, 14 (02)
  • [27] The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain
    Pinilla, Jaime
    Barber, Patricia
    Vallejo-Torres, Laura
    Rodriguez-Mireles, Silvia
    Lopez-Valcarcel, Beatriz G.
    Serra-Majem, Luis
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
  • [28] COVID-19 pandemic crisis—a complete outline of SARS-CoV-2
    Sana Saffiruddin Shaikh
    Anooja P. Jose
    Disha Anil Nerkar
    Midhuna Vijaykumar KV
    Saquib Khaleel Shaikh
    Future Journal of Pharmaceutical Sciences, 6
  • [29] The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training
    Pisani, Anthea
    Cremers, Isabelle
    Ellul, Pierre
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2021, 28 (06) : 379 - 384
  • [30] SARS-CoV-2 and acute respiratory sindrome pandemic (COVID-19)
    Ruiz-Bravo, Alfonso
    Jimenez-Valera, Maria
    ARS PHARMACEUTICA, 2020, 61 (02) : 63 - 79